Loading clinical trials...
Loading clinical trials...
This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT03918408 · Keratoconus, Unstable, Bacterial Keratitis, and more
NCT06451172 · Bacterial Keratitis, Antibiotic-resistant Bacteria, and more
NCT06271772 · Bacterial Keratitis
NCT04213885 · Keratoconus, Unstable, Ectasia Corneal, and more
NCT03845374 · Bacterial Keratitis
Galveston, Texas
Madurai, Tamil Nadu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions